RMD commentary, JAK kinase inhibitors: a preferred alternative to TNF inhibitors? by Vibeke Strand

Get full text

Summary of Research: Immunogenicity of Adalimumab Reference Product and Adalimumab-adbm in Patients with Rheumatoid Arthritis, Crohn’s Disease, and Chronic Plaque Psoriasis: A Pool... by Vibeke Strand

Get full text

Holistic approaches in systemic lupus erythematosus: do physicians avoid addressing difficult-to-treat but highly relevant symptoms? by Vibeke Strand, Christopher Sjöwall, Chris Wincup, Ioannis Parodis, Zahi Touma, Jeanette Andersen

Get full text

What Matters in Psoriatic Arthritis: A Comparison of Patient and Clinician Perspectives by Philip J. Mease, M. Elaine Husni, Evan Siegel, Daniel E. Furst, Melissa Mcilraith, Vibeke Strand, M. Cameron Hay

Get full text

Deucravacitinib, an oral, selective, allosteric, tyrosine kinase 2 inhibitor, in patients with active SLE: efficacy on patient-reported outcomes in a phase II randomised trial by Laurent Arnaud, Marta Mosca, Anca Askanase, Vibeke Strand, Subhashis Banerjee, Shalabh Singhal, Coburn Hobar, Samantha Pomponi, Brandon Becker, Jiyoon Choi

Get full text

Fosdagrocorat (PF-04171327) versus prednisone or placebo in rheumatoid arthritis: a randomised, double-blind, multicentre, phase IIb study by Frank Buttgereit, Dorothy McCabe, Eun Bong Lee, Vibeke Strand, Abraham Simon-Campos, Astrid Genet, Brinda Tammara, Ricardo Rojo, Judith Hey-Hadavi

Get full text

Tofacitinib or adalimumab versus placebo: patient-reported outcomes from OPAL Broaden—a phase III study of active psoriatic arthritis in patients with an inadequate response to con... by Philip J Mease, Dafna D Gladman, Vibeke Strand, Kurt de Vlam, Jose A Covarrubias-Cobos, Daniela Graham, Cunshan Wang, Joseph C Cappelleri, Thijs Hendrikx, Ming-Ann Hsu

Get full text

Effect of tofacitinib on patient-reported outcomes in patients with active psoriatic arthritis and an inadequate response to tumour necrosis factor inhibitors in the phase III, ran... by Philip J Mease, Dafna D Gladman, Vibeke Strand, Kurt de Vlam, Jose A Covarrubias-Cobos, Joseph C Cappelleri, Thijs Hendrikx, Ming-Ann Hsu, Linda Chen, Elizabeth Kudlacz, Joseph Wu

Get full text

Safety and efficacy of switching from adalimumab to sarilumab in patients with rheumatoid arthritis in the ongoing MONARCH open-label extension by Gerd R Burmester, Mark C Genovese, Vibeke Strand, Gregory St John, Andrea Rubbert-Roth, Howard Amital, Tatiana Raskina, Antonio Gómez-Centeno, Claudia Pena-Rossi, Leon Gervitz, Karthinathan Thangavelu, Susan Boklage

Get full text

Deucravacitinib in Patients with Plaque Psoriasis Who Screened Positive for Psoriatic Arthritis: Improvements in Joint Pain and the Impact of Musculoskeletal Symptoms by Joseph F. Merola, Philip J. Mease, April W. Armstrong, Vibeke Strand, Thomas Lehman, Stefan Varga, Jiyoon C. Choi, Brandon Becker, Yichen Zhong, Matthew J. Colombo, Diamant Thaçi, Androniki Bili, Alice B. Gottlieb

Get full text

Long-term safety and efficacy of anti-GM-CSF otilimab in patients with rheumatoid arthritis: long-term extension of three phase 3 randomised trials (contRAst X) by Tsutomu Takeuchi, Iain B McInnes, Peter C Taylor, Roy M Fleischmann, Vibeke Strand, Michael E Weinblatt, David Brooks, Tatsuya Atsumi, Paula Curtis, Marguerite Bracher, Anubha Gupta, Didier Saurigny, Celia Shelton, Millie Wang, Reena Wang, Rina Nijhawan, Ciara O'Shea, Kirsty Rayner

Get full text